Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus

References

• Hu K, Ding P, Wu Y, Tian W, Pan T, Zhang S. Global patterns and trends in the breast cancer incidence and mortality according to sociodemographic indices: an observational study based on the global burden of diseases. BMJ Open. 2019;9(10):e028461. doi:10.1136/bmjopen-2018-028461
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789. doi:10.1002/ijc.33588
   Web of Science ®Google Scholar
• Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–862. doi:10.1002/ijc.22717
   PubMed Web of Science ®Google Scholar
• Liao S, Li J, Wei W, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev. 2011;12(4):1061–1065.
   PubMed Web of Science ®Google Scholar
• Starup-Linde J, Karlstad O, Eriksen SA, et al. CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis. Curr Drug Saf. 2013;8(5):296–332. doi:10.2174/15748863113086660071
   PubMedGoogle Scholar
• Schrijnders D, Hendriks SH, Kleefstra N, et al. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49). PLoS One. 2018;13(1):e0190870. doi:10.1371/journal.pone.0190870
   PubMed Web of Science ®Google Scholar
• Brown KA. Metabolic pathways in obesity-related breast cancer. Nat Rev Endocrinol. 2021;17(6):350–363. doi:10.1038/s41574-021-00487-0
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
   PubMed Web of Science ®Google Scholar
• Boyle P, Koechlin A, Pizot C, et al. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis. Eur J Nutr. 2013;52(5):1533–1540. doi:10.1007/s00394-012-0460-z
   PubMed Web of Science ®Google Scholar
• Macacu A, Pizot C, Boyle P, Autier P. Risk of Breast Cancer According to Glycaemia and HbA1c Concentration — a Meta-analysis of Prospective Studies. Diabetes. 2018;67:1944–P. doi:10.2337/db18-1944-P
   Google Scholar
• Jung SY, Mancuso N, Han S, Zhang ZF. The Role of Genetically Determined Glycemic Traits in Breast Cancer: a Mendelian Randomization Study. Front Genet. 2020;11:540724. doi:10.3389/fgene.2020.540724
   PubMed Web of Science ®Google Scholar
• Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: new functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874(1):188394. doi:10.1016/j.bbcan.2020.188394
   PubMed Web of Science ®Google Scholar
• Touvier M, Fassier P, His M, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 2015;114(3):347–357. doi:10.1017/S000711451500183X
   PubMed Web of Science ®Google Scholar
• Ganjali S, Banach M, Pirro M, Fras Z, Sahebkar A. HDL and cancer - causality still needs to be confirmed? Update 2020. Semin Cancer Biol. 2021;73:169–177. doi:10.1016/j.semcancer.2020.10.007
   PubMed Web of Science ®Google Scholar
• Johnson KE, Siewert KM, Klarin D, et al. The relationship between circulating lipids and breast cancer risk: a Mendelian randomization study. PLoS Med. 2020;17(9):e1003302. doi:10.1371/journal.pmed.1003302
   PubMed Web of Science ®Google Scholar
• Beeghly-Fadiel A, Khankari NK, Delahanty RJ, et al. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk. Int J Epidemiol. 2020;49(4):1117–1131. doi:10.1093/ije/dyz242
   PubMed Web of Science ®Google Scholar
• Nowak C, Arnlov J. A Mendelian randomization study of the effects of blood lipids on breast cancer risk. Nat Commun. 2018;9(1):3957. doi:10.1038/s41467-018-06467-9
   PubMed Web of Science ®Google Scholar
• Orho-Melander M, Hindy G, Borgquist S, et al. Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study. Int J Epidemiol. 2018;47(2):495–505. doi:10.1093/ije/dyx237
   PubMed Web of Science ®Google Scholar
• Ni H, Liu H, Gao R. Serum Lipids and Breast Cancer Risk: a Meta-Analysis of Prospective Cohort Studies. PLoS One. 2015;10(11):e0142669. doi:10.1371/journal.pone.0142669
   PubMed Web of Science ®Google Scholar
• Ma HQ, Cui LH, Li CC, Yu Z, Piao JM. Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: a Meta-Analysis of Prospective Studies. Nutr Cancer. 2016;68(7):1073–1082. doi:10.1080/01635581.2016.1206582
   PubMed Web of Science ®Google Scholar
• Ambroz M, de Vries ST, Vart P, et al. Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: a Primary Care-Based Study. J Clin Med. 2021;10(8):1775. doi:10.3390/jcm10081775
   PubMed Web of Science ®Google Scholar
• Balder JW, de Vries JK, Nolte IM, Lansberg PJ, Kuivenhoven JA, Kamphuisen PW. Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles. J Clin Lipidol. 2017;11(4):1055–1064e6. doi:10.1016/j.jacl.2017.05.007
   PubMed Web of Science ®Google Scholar
• Goldberg IJ. Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–971. doi:10.1210/jcem.86.3.7304
   PubMed Web of Science ®Google Scholar
• Farbstein D, Levy AP. HDL dysfunction in diabetes: causes and possible treatments. Expert Rev Cardiovasc Ther. 2012;10(3):353–361. doi:10.1586/erc.11.182
   PubMedGoogle Scholar
• Mancini GBJ, Hegele RA, Leiter LA; Diabetes Canada Clinical Practice Guidelines Expert C. Dyslipidemia. Can J Diabetes. 2018;42(Suppl 1):S178–S185. doi:10.1016/j.jcjd.2017.10.019
   PubMed Web of Science ®Google Scholar
• Authors/Task Force M, Guidelines ESCCfP, Societies ESCNC. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. doi:10.1016/j.atherosclerosis.2019.08.014
   PubMed Web of Science ®Google Scholar
• Zhao W, Guan J, Horswell R, et al. HDL cholesterol and cancer risk among patients with type 2 diabetes. Diabetes Care. 2014;37(12):3196–3203. doi:10.2337/dc14-0523
   PubMed Web of Science ®Google Scholar
• Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327–338. doi:10.2147/DMSO.S51325
   PubMedGoogle Scholar
• Seretis A, Cividini S, Markozannes G, et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci Rep. 2019;9(1):8565. doi:10.1038/s41598-019-45014-4
   PubMedGoogle Scholar
• Yang Y, Lynch BM, Hodge AM, et al. Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study. J Hypertens. 2017;35(7):1371–1380. doi:10.1097/HJH.0000000000001372
   PubMed Web of Science ®Google Scholar
• Christakoudi S, Kakourou A, Markozannes G, et al. Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2020;146(10):2680–2693. doi:10.1002/ijc.32576
   PubMed Web of Science ®Google Scholar
• Rutten G, De Grauw W, Nijpels G, et al. NHG-Standaard Diabetes mellitus type 2 (derde herziening). Huisarts Wet. 2013;56(10):512–525.
   Google Scholar
• de Vries FM, Voorham J, Hak E, Denig P. Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients. Curr Med Res Opin. 2015;31(12):2197–2206. doi:10.1185/03007995.2015.1092126
   PubMed Web of Science ®Google Scholar
• Lamberts H, Wood M, eds. International Classification of Primary Care (ICPC). Oxford:: Oxford University Press; 1987.
   Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399. doi:10.1002/sim.4067
   PubMed Web of Science ®Google Scholar
• Grambsch P. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–526. doi:10.1093/biomet/81.3.515
   Web of Science ®Google Scholar
• Fine JP. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509. doi:10.1080/01621459.1999.10474144
   Web of Science ®Google Scholar
• Nelson ER, Chang CY, McDonnell DP. Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab. 2014;25(12):649–655. doi:10.1016/j.tem.2014.10.001
   PubMed Web of Science ®Google Scholar
• Yang X, So WY, Ma RC, et al. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. Endocr Relat Cancer. 2008;15(2):597–607. doi:10.1677/ERC-07-0266
   PubMed Web of Science ®Google Scholar
• Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5(4):378–387. doi:10.1111/j.1582-4934.2001.tb00172.x
   PubMed Web of Science ®Google Scholar
• Islam MM, Yang HC, Nguyen PA, et al. Exploring association between statin use and breast cancer risk: an updated meta-analysis. Arch Gynecol Obstet. 2017;296(6):1043–1053. doi:10.1007/s00404-017-4533-3
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Sarwar N. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. doi:10.1001/jama.2009.1619
   PubMed Web of Science ®Google Scholar
• Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478–2486. doi:10.1093/eurheartj/ehx163
   PubMed Web of Science ®Google Scholar
• Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes?. Curr Diab Rep. 2008;8(1):51–59.
   PubMed Web of Science ®Google Scholar
• Mazzuferi G, Bacchetti T, Islam MO, Ferretti G. High density lipoproteins and oxidative stress in breast cancer. Lipids Health Dis. 2021;20(1):143. doi:10.1186/s12944-021-01562-1
   PubMed Web of Science ®Google Scholar
• Cedo L, Reddy ST, Mato E, Blanco-Vaca F, Escola-Gil JC. HDL and LDL: potential New Players in Breast Cancer Development. J Clin Med. 2019;8(6):853. doi:10.3390/jcm8060853
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, Zelenko Z, Neel BA, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene. 2017;36(46):6462–6471. doi:10.1038/onc.2017.247
   PubMed Web of Science ®Google Scholar
• Yang X, So W, Ko GT, et al. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. CMAJ. 2008;179(5):427–437. doi:10.1503/cmaj.071474
   PubMed Web of Science ®Google Scholar
• Yang X, Ma RC, So WY, et al. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry. Cancer. 2011;117(4):862–871. doi:10.1002/cncr.25455
   PubMed Web of Science ®Google Scholar
• Jarc E, Eichmann TO, Zimmermann R, Petan T. Lipidomic data on lipid droplet triglyceride remodelling associated with protection of breast cancer cells from lipotoxic stress. Data Brief. 2018;18:234–240. doi:10.1016/j.dib.2018.03.033
   PubMed Web of Science ®Google Scholar
• Munir R, Lisec J, Swinnen JV, Zaidi N. Lipid metabolism in cancer cells under metabolic stress. Br J Cancer. 2019;120(12):1090–1098. doi:10.1038/s41416-019-0451-4
   PubMed Web of Science ®Google Scholar
• Pan B, Ren H, Ma Y, et al. High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer. 2012;131(1):70–82. doi:10.1002/ijc.26341
   PubMed Web of Science ®Google Scholar
• Bonilha I, Zimetti F, Zanotti I, Papotti B, Sposito AC. Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: molecular Mechanisms and Therapeutic Implications. J Clin Med. 2021;10(11):2233. doi:10.3390/jcm10112233
   PubMed Web of Science ®Google Scholar
• Sobal G, Menzel J, Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids. 2000;63(4):177–186. doi:10.1054/plef.2000.0204
   PubMed Web of Science ®Google Scholar
• Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes Dyslipidemia. Diabetes Ther. 2016;7(2):203–219. doi:10.1007/s13300-016-0167-x
   PubMed Web of Science ®Google Scholar
• His M, Zelek L, Deschasaux M, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 2014;29(2):119–132. doi:10.1007/s10654-014-9884-5
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Barbosa AM, Martel F. Targeting Glucose Transporters for Breast Cancer Therapy: the Effect of Natural and Synthetic Compounds. Cancers. 2020;12(1):154. doi:10.3390/cancers12010154
   PubMed Web of Science ®Google Scholar
• Lin C, Cai X, Yang W, Lv F, Nie L, Ji L. Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Endocrine. 2020;70(2):232–242. doi:10.1007/s12020-020-02376-4
   PubMed Web of Science ®Google Scholar
• Siedlinski M, Jozefczuk E, Xu X, et al. White Blood Cells and Blood Pressure: a Mendelian Randomization Study. Circulation. 2020;141(16):1307–1317. doi:10.1161/CIRCULATIONAHA.119.045102
   PubMed Web of Science ®Google Scholar
• Carnevale D, Lembo G. Immunological Aspects of Hypertension. High Blood Press Cardiovasc Prev. 2016;23(2):91–95. doi:10.1007/s40292-016-0141-8
   PubMedGoogle Scholar
• Sanidas E, Velliou M, Papadopoulos D, et al. Antihypertensive Drugs and Risk of Cancer: between Scylla and Charybdis. Am J Hypertens. 2020;33(12):1049–1058. doi:10.1093/ajh/hpaa098
   PubMed Web of Science ®Google Scholar
• Voorham J, Denig P. Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners. J Am Med Inform Assoc. 2007;14(3):349–354. doi:10.1197/jamia.M2128
   PubMed Web of Science ®Google Scholar
• Olsson H, Baldetorp B, Ferno M, Perfekt R. Relation between the rate of tumour cell proliferation and latency time in radiation associated breast cancer. BMC Cancer. 2003;3:11. doi:10.1186/1471-2407-3-11
   PubMed Web of Science ®Google Scholar
• Diana L, Nadler IGZ. Estimating Cancer Latency Times Using a Weibull Model. Adv Epidemiol. 2014;2014:1–8. doi:10.1155/2014/746769
   Google Scholar